Skip to main content
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
Abstract 54: Integrative analysis of whole-genome and RNA sequencing in high-risk pediatric malignancies.
Abstract CT015: A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma.
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.
Abstract B20: Integrative analysis of whole-genome and RNA sequencing in high-risk pediatric malignancies.
Abstract B13: Leveraging cloud-based computational resources for gene fusion discovery with potential clinical implications for pediatric solid tumor patients.
Abstract A59: Sequencing identifies diagnostically relevant alterations in pediatric solid tumor patients.
Abstract A27: An apoptosis-based screen for targeted agents in rhabdomyosarcoma reveals potential combination therapies.
Abstract A06: The added value of examining germline variants in a precision cancer therapy study.